These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35637839)

  • 1. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
    Int J Nanomedicine; 2022; 17():2319-2320. PubMed ID: 35637839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A redox-responsive strategy using mesoporous silica nanoparticles for co-delivery of siRNA and doxorubicin.
    Zhao S; Xu M; Cao C; Yu Q; Zhou Y; Liu J
    J Mater Chem B; 2017 Sep; 5(33):6908-6919. PubMed ID: 32264340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
    Bhavsar DB; Patel V; Sawant KK
    Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum].
    Int J Nanomedicine; 2021; 16():7859-7860. PubMed ID: 34880611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3055-3056. PubMed ID: 35836837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of pH-Responsive and Polyethylene Glycol-Modified Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Drug Delivery.
    Qin Y; Shan X; Han Y; Jin H; Gao Y
    J Nanosci Nanotechnol; 2020 Oct; 20(10):5997-6006. PubMed ID: 32384944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy.
    Tian Y; Guo R; Jiao Y; Sun Y; Shen S; Wang Y; Lu D; Jiang X; Yang W
    Nanoscale Horiz; 2016 Nov; 1(6):480-487. PubMed ID: 32260712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyl Wrinkled Mesoporous Silica Nanoparticles for pH-Responsive Doxorubicin Drug Delivery.
    Lin J; Peng C; Ravi S; Siddiki AKMNA; Zheng J; Balkus KJ
    Materials (Basel); 2020 Apr; 13(8):. PubMed ID: 32344722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery.
    Chen X; Sun H; Hu J; Han X; Liu H; Hu Y
    Colloids Surf B Biointerfaces; 2017 Apr; 152():77-84. PubMed ID: 28088015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery.
    Lin JT; Du JK; Yang YQ; Li L; Zhang DW; Liang CL; Wang J; Mei J; Wang GH
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():478-484. PubMed ID: 28888000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system.
    Kundu M; Sadhukhan P; Ghosh N; Ghosh S; Chatterjee S; Das J; Brahmachari G; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112142. PubMed ID: 34082953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe
    Int J Nanomedicine; 2020; 15():5573-5574. PubMed ID: 32848388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.